Breye Therapeutics

BiotechnologySeries ADenmarkbreye.com

Latest round

Series A

Last raised

Sep 2026

Total raised

$81M

Investors

11

About Breye Therapeutics

Based in Copenhagen, Denmark, and founded in 2019, Breye Therapeutics ApS operates as a biopharmaceutical company that develops and provides ophthalmology therapies for retinal vascular diseases. The company was founded by its CEO, Ulrik Mouritzen. The company focuses on providing therapeutic options for people who are at risk of vision loss or blindness due to retinal vascular disorders. They specialize in producing tiny compounds that can be taken orally, with a focus on diabetic retinopathy (DR) and age-related macular degeneration (AMD).

Who invested in Breye Therapeutics

11 investors across 2 rounds

See all investors in Breye Therapeutics

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Sep 29, 2026

    Amount

    $77M

    Investors

    Locked

  2. Seed

    Nov 10, 2022

    Amount

    $4.1M

    Investors

    Locked

Questions about Breye Therapeutics

Who invested in Breye Therapeutics?

Breye Therapeutics has 11 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Breye Therapeutics raised?

Breye Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did Breye Therapeutics last raise money?

Breye Therapeutics's most recent round on record is a Series A, in Sep 2026.

What does Breye Therapeutics do?

Based in Copenhagen, Denmark, and founded in 2019, Breye Therapeutics ApS operates as a biopharmaceutical company that develops and provides ophthalmology therapies for retinal vascular diseases.

Where is Breye Therapeutics headquartered?

Breye Therapeutics is headquartered in Denmark.

Which VCs invest in companies like Breye Therapeutics?

Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Breye Therapeutics's stage. Their profiles are linked below.

Raising like Breye Therapeutics? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.